Your one-stop-shop
for preclinical development
From discovery to first-in-human, easy!
Route 21 is a startup born in 2022 fully dedicated to the creation of an European-wide one-stop-shop aimed at supporting startups and pharma companies in their preclinical development activities, «from Discovery to 1st in Human».Our platform stands as a comprehensive tool for both the identification of the most suitable activity needed by your project, ranging from target discovery to first-in-human clinical trials, and the connection with the right partner to bring you research to the next step of development.
"Our aim is to change the paradigm of how preclinical research activities are done,
building a wide ecosystem of research services supporting each aspect of the discovery and pre-development phase."
Vladimir Kocsubej, CEO - Route21
Meet our team
"We boast an international presence
representing a network of niche service providers supporting your preclinical projects, spanning throughout Europe."
Beatrice Riva, CSO - Route21
Meet our team
